The FDA issued the warning letter on June 21, 2010 as a result of deficiencies in Alphatec Spine’s letter regarding an FDA inspection that occurred in Feb. 2010. A follow-up audit of the company’s facility resulted in an FDA issued close-out letter dated Sept. 28, 2011, that stated the company has resolved issues stated in the letter of warning.
Related Articles on Orthopedic Device Companies:
Orthofix Promotes Bryan McMillan to President of Spine Global Business Unit
K2M Announces Two New Cervical Spine Devices
Zimmer Sponsors 2011 Zimmer Winter National Senior Games
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.